Skip to main content
Top
Published in: European Radiology 2/2007

01-02-2007 | Molecular Imaging

Gene expression and gene therapy imaging

Authors: Claire Rome, Franck Couillaud, Chrit T. W. Moonen

Published in: European Radiology | Issue 2/2007

Login to get access

Abstract

The fast growing field of molecular imaging has achieved major advances in imaging gene expression, an important element of gene therapy. Gene expression imaging is based on specific probes or contrast agents that allow either direct or indirect spatio-temporal evaluation of gene expression. Direct evaluation is possible with, for example, contrast agents that bind directly to a specific target (e.g., receptor). Indirect evaluation may be achieved by using specific substrate probes for a target enzyme. The use of marker genes, also called reporter genes, is an essential element of MI approaches for gene expression in gene therapy. The marker gene may not have a therapeutic role itself, but by coupling the marker gene to a therapeutic gene, expression of the marker gene reports on the expression of the therapeutic gene. Nuclear medicine and optical approaches are highly sensitive (detection of probes in the picomolar range), whereas MRI and ultrasound imaging are less sensitive and require amplification techniques and/or accumulation of contrast agents in enlarged contrast particles. Recently developed MI techniques are particularly relevant for gene therapy. Amongst these are the possibility to track gene therapy vectors such as stem cells, and the techniques that allow spatiotemporal control of gene expression by non-invasive heating (with MRI guided focused ultrasound) and the use of temperature sensitive promoters.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672PubMedCrossRef Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672PubMedCrossRef
2.
go back to reference Wunderbaldinger P, Bogdanov A, Weissleder R (2000) New approaches for imaging in gene therapy. Eur J Radiol 34:156–165PubMedCrossRef Wunderbaldinger P, Bogdanov A, Weissleder R (2000) New approaches for imaging in gene therapy. Eur J Radiol 34:156–165PubMedCrossRef
3.
go back to reference Bogdanov AA Jr., Simonova M, Weissleder R (2000) Engineering membrane proteins for nuclear medicine: applications for gene therapy and cell tracking. Q J Nucl Med 44:224–235PubMed Bogdanov AA Jr., Simonova M, Weissleder R (2000) Engineering membrane proteins for nuclear medicine: applications for gene therapy and cell tracking. Q J Nucl Med 44:224–235PubMed
4.
go back to reference Reader AJ, Zweit J (2001) Developments in whole-body molecular imaging of live subjects. Trends Pharmacol Sci 22:604–607PubMedCrossRef Reader AJ, Zweit J (2001) Developments in whole-body molecular imaging of live subjects. Trends Pharmacol Sci 22:604–607PubMedCrossRef
5.
go back to reference Jacobs AH, Dittmar C, Winkeler A, Garlip G, Heiss WD (2002) Molecular imaging of gliomas. Mol Imaging 1:309–335PubMedCrossRef Jacobs AH, Dittmar C, Winkeler A, Garlip G, Heiss WD (2002) Molecular imaging of gliomas. Mol Imaging 1:309–335PubMedCrossRef
6.
go back to reference Shah K, Jacobs A, Breakefield XO, Weissleder R (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11:1175–1187PubMedCrossRef Shah K, Jacobs A, Breakefield XO, Weissleder R (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11:1175–1187PubMedCrossRef
7.
go back to reference van Roessel P, Brand AH (2002) Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins. Nat Cell Biol 4:E15–E20PubMedCrossRef van Roessel P, Brand AH (2002) Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins. Nat Cell Biol 4:E15–E20PubMedCrossRef
8.
go back to reference Weissleder R, Ntziachristos V (2003) Shedding light onto live molecular targets. Nat Med 9:123–128PubMedCrossRef Weissleder R, Ntziachristos V (2003) Shedding light onto live molecular targets. Nat Med 9:123–128PubMedCrossRef
9.
go back to reference Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66:523–531PubMed Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66:523–531PubMed
10.
go back to reference Turnbull DH, Ramsay JA, Shivji GS, Bloomfield TS, From L, Sauder DN, Foster FS (1996) Ultrasound backscatter microscope analysis of mouse melanoma progression. Ultrasound Med Biol 22:845–853PubMedCrossRef Turnbull DH, Ramsay JA, Shivji GS, Bloomfield TS, From L, Sauder DN, Foster FS (1996) Ultrasound backscatter microscope analysis of mouse melanoma progression. Ultrasound Med Biol 22:845–853PubMedCrossRef
11.
go back to reference Turnbull DH, Bloomfield TS, Baldwin HS, Foster FS, Joyner AL (1995) Ultrasound backscatter microscope analysis of early mouse embryonic brain development. Proc Natl Acad Sci U S A 92:2239–2243PubMedCrossRef Turnbull DH, Bloomfield TS, Baldwin HS, Foster FS, Joyner AL (1995) Ultrasound backscatter microscope analysis of early mouse embryonic brain development. Proc Natl Acad Sci U S A 92:2239–2243PubMedCrossRef
12.
go back to reference Hildebrandt IJ, Gambhir SS (2004) Molecular imaging applications for immunology. Clin Immunol 111:210–224PubMedCrossRef Hildebrandt IJ, Gambhir SS (2004) Molecular imaging applications for immunology. Clin Immunol 111:210–224PubMedCrossRef
13.
go back to reference Weissleder R (2002) Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2:11–18PubMedCrossRef Weissleder R (2002) Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2:11–18PubMedCrossRef
14.
go back to reference Liang HD, Blomley MJ (2003) The role of ultrasound in molecular imaging. Br J Radiol 76(Spec No 2):S140–S150PubMedCrossRef Liang HD, Blomley MJ (2003) The role of ultrasound in molecular imaging. Br J Radiol 76(Spec No 2):S140–S150PubMedCrossRef
15.
go back to reference Jain KK (2004) Role of pharmacoproteomics in the development of personalized medicine. Pharmacogenomics 5:331–336PubMedCrossRef Jain KK (2004) Role of pharmacoproteomics in the development of personalized medicine. Pharmacogenomics 5:331–336PubMedCrossRef
16.
go back to reference Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63:2723–2727PubMed Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63:2723–2727PubMed
17.
go back to reference Noble ME, Endicott JA, Johnson LN (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303:1800–1805PubMedCrossRef Noble ME, Endicott JA, Johnson LN (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303:1800–1805PubMedCrossRef
18.
go back to reference Waldherr C, Pless M, Maecke HR, Schumacher T, Crazzolara A, Nitzsche EU, Haldemann A, Mueller-Brand J (2002) Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC. J Nucl Med 43:610–616PubMed Waldherr C, Pless M, Maecke HR, Schumacher T, Crazzolara A, Nitzsche EU, Haldemann A, Mueller-Brand J (2002) Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC. J Nucl Med 43:610–616PubMed
19.
go back to reference Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, Kapiotis S, Hamwi A, Weich HA, Valent P, Angelberger P, Dudczak R, Virgolini I (2001) Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer 91:789–796PubMedCrossRef Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, Kapiotis S, Hamwi A, Weich HA, Valent P, Angelberger P, Dudczak R, Virgolini I (2001) Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer 91:789–796PubMedCrossRef
20.
go back to reference MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herschman HR (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785–791PubMedCrossRef MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herschman HR (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785–791PubMedCrossRef
21.
go back to reference Rogers BE, McLean SF, Kirkman RL, Della Manna D, Bright SJ, Olsen CC, Myracle AD, Mayo MS, Curiel DT, Buchsbaum DJ (1999) In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res 5:383–393PubMed Rogers BE, McLean SF, Kirkman RL, Della Manna D, Bright SJ, Olsen CC, Myracle AD, Mayo MS, Curiel DT, Buchsbaum DJ (1999) In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res 5:383–393PubMed
22.
go back to reference De Santes K, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D, Press O (1992) Radiolabeled antibody targeting of the HER-2/neu oncoprotein. Cancer Res 52:1916–1923PubMed De Santes K, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D, Press O (1992) Radiolabeled antibody targeting of the HER-2/neu oncoprotein. Cancer Res 52:1916–1923PubMed
23.
go back to reference Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM (2005) Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 53:621–627PubMedCrossRef Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM (2005) Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 53:621–627PubMedCrossRef
24.
25.
go back to reference Santra S, Xu J, Wang K, Tan W (2004) Luminescent nanoparticle probes for bioimaging. J Nanosci Nanotechnol 4:590–599PubMedCrossRef Santra S, Xu J, Wang K, Tan W (2004) Luminescent nanoparticle probes for bioimaging. J Nanosci Nanotechnol 4:590–599PubMedCrossRef
26.
go back to reference Chung JK (2002) Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188–1200PubMed Chung JK (2002) Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188–1200PubMed
27.
go back to reference Chung JK, Kang JH (2004) Translational research using the sodium/iodide symporter in imaging and therapy. Eur J Nucl Med Mol Imaging 31:799–802PubMedCrossRef Chung JK, Kang JH (2004) Translational research using the sodium/iodide symporter in imaging and therapy. Eur J Nucl Med Mol Imaging 31:799–802PubMedCrossRef
28.
go back to reference Ichikawa T, Hogemann D, Saeki Y, Tyminski E, Terada K, Weissleder R, Chiocca EA, Basilion JP (2002) MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 4:523–530PubMedCrossRef Ichikawa T, Hogemann D, Saeki Y, Tyminski E, Terada K, Weissleder R, Chiocca EA, Basilion JP (2002) MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 4:523–530PubMedCrossRef
29.
go back to reference Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, Basilion JP (2003) The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia 5:495–506PubMed Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, Basilion JP (2003) The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia 5:495–506PubMed
30.
go back to reference Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351–355PubMedCrossRef Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351–355PubMedCrossRef
31.
go back to reference Tung CH, Mahmood U, Bredow S, Weissleder R (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60:4953–4958PubMed Tung CH, Mahmood U, Bredow S, Weissleder R (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60:4953–4958PubMed
32.
go back to reference Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743–748PubMedCrossRef Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743–748PubMedCrossRef
33.
go back to reference Ntziachristos V, Tung CH, Bremer C, Weissleder R (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8:757–760PubMedCrossRef Ntziachristos V, Tung CH, Bremer C, Weissleder R (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8:757–760PubMedCrossRef
34.
go back to reference Vihinen P, Kahari VM (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99:157–166PubMedCrossRef Vihinen P, Kahari VM (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99:157–166PubMedCrossRef
35.
go back to reference Bogdanov A, Jr., Matuszewski L, Bremer C, Petrovsky A, Weissleder R (2002) Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 1:16–23PubMedCrossRef Bogdanov A, Jr., Matuszewski L, Bremer C, Petrovsky A, Weissleder R (2002) Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 1:16–23PubMedCrossRef
36.
go back to reference Chen JW, Pham W, Weissleder R, Bogdanov A Jr (2004) Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med 52:1021–1028PubMedCrossRef Chen JW, Pham W, Weissleder R, Bogdanov A Jr (2004) Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med 52:1021–1028PubMedCrossRef
37.
go back to reference Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, Gambhir SS (2005) Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 12:329–339PubMedCrossRef Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, Gambhir SS (2005) Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 12:329–339PubMedCrossRef
38.
go back to reference Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18:321–325PubMedCrossRef Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18:321–325PubMedCrossRef
39.
go back to reference Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R (2004) In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 64:1579–1583PubMedCrossRef Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R (2004) In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 64:1579–1583PubMedCrossRef
40.
41.
go back to reference Wu JC, Inubushi M, Sundaresan G, Schelbert HR, Gambhir SS (2002) Optical imaging of cardiac reporter gene expression in living rats. Circulation 105:1631–1634PubMedCrossRef Wu JC, Inubushi M, Sundaresan G, Schelbert HR, Gambhir SS (2002) Optical imaging of cardiac reporter gene expression in living rats. Circulation 105:1631–1634PubMedCrossRef
42.
go back to reference de Boer J, van Blitterswijk C, Lowik C (2006) Bioluminescent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials 27:1851–1858PubMedCrossRef de Boer J, van Blitterswijk C, Lowik C (2006) Bioluminescent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials 27:1851–1858PubMedCrossRef
43.
go back to reference Marignol L, Lawler M, Coffey M, Hollywood D (2005) Achieving hypoxia-inducible gene expression in tumors. Cancer Biol Ther 4:359–364PubMedCrossRef Marignol L, Lawler M, Coffey M, Hollywood D (2005) Achieving hypoxia-inducible gene expression in tumors. Cancer Biol Ther 4:359–364PubMedCrossRef
44.
go back to reference Murdoch C, Lewis CE (2005) Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 117:701–708PubMedCrossRef Murdoch C, Lewis CE (2005) Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 117:701–708PubMedCrossRef
45.
go back to reference Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, Harris AL (1997) Targeting gene expression to hypoxic tumor cells. Nat Med 3:515–520PubMedCrossRef Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, Harris AL (1997) Targeting gene expression to hypoxic tumor cells. Nat Med 3:515–520PubMedCrossRef
46.
go back to reference Liu J, Qu R, Ogura M, Shibata T, Harada H, Hiraoka M (2005) Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts. J Radiat Res (Tokyo) 46:93–102CrossRef Liu J, Qu R, Ogura M, Shibata T, Harada H, Hiraoka M (2005) Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts. J Radiat Res (Tokyo) 46:93–102CrossRef
47.
go back to reference Huang D, Desbois A, Hou ST (2005) A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons. Gene Ther 12:1369–1376PubMedCrossRef Huang D, Desbois A, Hou ST (2005) A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons. Gene Ther 12:1369–1376PubMedCrossRef
48.
go back to reference Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan CW, Slack M, Sadelain M, Breakefield XO, Tjuvajev JG (1999) Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia 1:154–161PubMedCrossRef Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan CW, Slack M, Sadelain M, Breakefield XO, Tjuvajev JG (1999) Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia 1:154–161PubMedCrossRef
49.
go back to reference Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, Humm J, Larson S, Sadelain M, Blasberg R, Gelovani Tjuvajev J (2001) Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A 98:9300–9305PubMedCrossRef Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, Humm J, Larson S, Sadelain M, Blasberg R, Gelovani Tjuvajev J (2001) Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A 98:9300–9305PubMedCrossRef
50.
go back to reference Sato M, Johnson M, Zhang L, Zhang B, Le K, Gambhir SS, Carey M, Wu L (2003) Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther 8:726–737PubMedCrossRef Sato M, Johnson M, Zhang L, Zhang B, Le K, Gambhir SS, Carey M, Wu L (2003) Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther 8:726–737PubMedCrossRef
51.
go back to reference Cheng WS, Kraaij R, Nilsson B, van der Weel L, de Ridder CM, Totterman TH, Essand M (2004) A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer. Mol Ther 10:355–364PubMedCrossRef Cheng WS, Kraaij R, Nilsson B, van der Weel L, de Ridder CM, Totterman TH, Essand M (2004) A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer. Mol Ther 10:355–364PubMedCrossRef
52.
go back to reference Iyer M, Salazar FB, Wu L, Carey M, Gambhir SS (2006) Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector. Hum Gene Ther 17:125–132PubMedCrossRef Iyer M, Salazar FB, Wu L, Carey M, Gambhir SS (2006) Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector. Hum Gene Ther 17:125–132PubMedCrossRef
53.
go back to reference Iyer M, Salazar FB, Lewis X, Zhang L, Carey M, Wu L, Gambhir SS (2004) Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 10:545–552PubMedCrossRef Iyer M, Salazar FB, Lewis X, Zhang L, Carey M, Wu L, Gambhir SS (2004) Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 10:545–552PubMedCrossRef
54.
go back to reference Adams JY, Johnson M, Sato M, Berger F, Gambhir SS, Carey M, Iruela-Arispe ML, Wu L (2002) Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8:891–897PubMed Adams JY, Johnson M, Sato M, Berger F, Gambhir SS, Carey M, Iruela-Arispe ML, Wu L (2002) Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8:891–897PubMed
55.
56.
go back to reference Phelps ME (2000) PET: the merging of biology and imaging into molecular imaging. J Nucl Med 41:661–681PubMed Phelps ME (2000) PET: the merging of biology and imaging into molecular imaging. J Nucl Med 41:661–681PubMed
57.
go back to reference Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE, Barnes MN, Alvarez RD, Curiel DT (2002) In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. J Natl Cancer Inst 94:741–749PubMed Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE, Barnes MN, Alvarez RD, Curiel DT (2002) In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. J Natl Cancer Inst 94:741–749PubMed
58.
go back to reference Altmann A, Kissel M, Zitzmann S, Kubler W, Mahmut M, Peschke P, Haberkorn U (2003) Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma. J Nucl Med 44:973–980PubMed Altmann A, Kissel M, Zitzmann S, Kubler W, Mahmut M, Peschke P, Haberkorn U (2003) Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma. J Nucl Med 44:973–980PubMed
59.
go back to reference Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727–729PubMedCrossRef Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727–729PubMedCrossRef
60.
go back to reference Reszka RC, Jacobs A, Voges J (2005) Liposome-mediated suicide gene therapy in humans. Methods Enzymol 391:200–208PubMed Reszka RC, Jacobs A, Voges J (2005) Liposome-mediated suicide gene therapy in humans. Methods Enzymol 391:200–208PubMed
61.
go back to reference Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD, Rehemtulla A (2002) Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A 99:16551–16555PubMedCrossRef Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD, Rehemtulla A (2002) Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A 99:16551–16555PubMedCrossRef
62.
go back to reference Hackman T, Doubrovin M, Balatoni J, Beresten T, Ponomarev V, Beattie B, Finn R, Bornmann W, Blasberg R, Tjuvajev JG (2002) Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging 1:36–42PubMedCrossRef Hackman T, Doubrovin M, Balatoni J, Beresten T, Ponomarev V, Beattie B, Finn R, Bornmann W, Blasberg R, Tjuvajev JG (2002) Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging 1:36–42PubMedCrossRef
63.
go back to reference Herschman HR (2003) Molecular imaging: looking at problems, seeing solutions. Science 302:605–608PubMedCrossRef Herschman HR (2003) Molecular imaging: looking at problems, seeing solutions. Science 302:605–608PubMedCrossRef
64.
go back to reference Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS, Bogdanov A Jr (1997) MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204:425–429PubMed Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS, Bogdanov A Jr (1997) MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204:425–429PubMed
65.
go back to reference Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–423PubMed Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–423PubMed
66.
go back to reference Bogdanov AA Jr, Weissleder R (2002) In vivo imaging of gene delivery and expression. Trends Biotech 20:511–518 Bogdanov AA Jr, Weissleder R (2002) In vivo imaging of gene delivery and expression. Trends Biotech 20:511–518
67.
go back to reference Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491–495PubMedCrossRef Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491–495PubMedCrossRef
68.
go back to reference Rudin M, Rausch M, Stoeckli M (2005) Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods. Mol Imaging Biol 7:5–13PubMedCrossRef Rudin M, Rausch M, Stoeckli M (2005) Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods. Mol Imaging Biol 7:5–13PubMedCrossRef
69.
go back to reference Thorne SH, Tam BY, Kirn DH, Contag CH, Kuo CJ (2006) Selective Intratumoral Amplification of an Antiangiogenic Vector by an Oncolytic Virus Produces Enhanced Antivascular and Anti-tumor Efficacy. Mol Ther Thorne SH, Tam BY, Kirn DH, Contag CH, Kuo CJ (2006) Selective Intratumoral Amplification of an Antiangiogenic Vector by an Oncolytic Virus Produces Enhanced Antivascular and Anti-tumor Efficacy. Mol Ther
70.
go back to reference Cronin J, Zhang XY, Reiser J (2005) Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5:387–398PubMedCrossRef Cronin J, Zhang XY, Reiser J (2005) Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5:387–398PubMedCrossRef
71.
go back to reference Pack DW, Hoffman AS, Pun S, Stayton PS (2005) Design and development of polymers for gene delivery. Nat Rev Drug Discov 4:581–593PubMedCrossRef Pack DW, Hoffman AS, Pun S, Stayton PS (2005) Design and development of polymers for gene delivery. Nat Rev Drug Discov 4:581–593PubMedCrossRef
72.
go back to reference Li C, Bowles DE, van Dyke T, Samulski RJ (2005) Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther 12:913–925PubMedCrossRef Li C, Bowles DE, van Dyke T, Samulski RJ (2005) Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther 12:913–925PubMedCrossRef
73.
go back to reference Barzon L, Stefani AL, Pacenti M, Palu G (2005) Versatility of gene therapy vectors through viruses. Expert Opin Biol Ther 5:639–662PubMedCrossRef Barzon L, Stefani AL, Pacenti M, Palu G (2005) Versatility of gene therapy vectors through viruses. Expert Opin Biol Ther 5:639–662PubMedCrossRef
74.
go back to reference Banerjee P, Reichardt W, Weissleder R, Bogdanov A Jr (2004) Novel hyperbranched dendron for gene transfer in vitro and in vivo. Bioconjug Chem 15:960–968PubMedCrossRef Banerjee P, Reichardt W, Weissleder R, Bogdanov A Jr (2004) Novel hyperbranched dendron for gene transfer in vitro and in vivo. Bioconjug Chem 15:960–968PubMedCrossRef
75.
go back to reference Meilander-Lin NJ, Cheung PJ, Wilson DL, Bellamkonda RV (2005) Sustained in vivo gene delivery from agarose hydrogel prolongs nonviral gene expression in skin. Tissue Eng 11:546–555PubMedCrossRef Meilander-Lin NJ, Cheung PJ, Wilson DL, Bellamkonda RV (2005) Sustained in vivo gene delivery from agarose hydrogel prolongs nonviral gene expression in skin. Tissue Eng 11:546–555PubMedCrossRef
76.
go back to reference Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R (2000) Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Ther 7:1648–1655PubMedCrossRef Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R (2000) Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Ther 7:1648–1655PubMedCrossRef
77.
go back to reference Unger EC, Hersh E, Vannan M, McCreery T (2001) Gene delivery using ultrasound contrast agents. Echocardiography 18:355–361PubMedCrossRef Unger EC, Hersh E, Vannan M, McCreery T (2001) Gene delivery using ultrasound contrast agents. Echocardiography 18:355–361PubMedCrossRef
78.
go back to reference Bos C, Lepetit-Coiffe M, Quesson B, Moonen CT (2005) Simultaneous monitoring of temperature and T1: methods and preliminary results of application to drug delivery using thermosensitive liposomes. Magn Reson Med 54:1020–1024PubMedCrossRef Bos C, Lepetit-Coiffe M, Quesson B, Moonen CT (2005) Simultaneous monitoring of temperature and T1: methods and preliminary results of application to drug delivery using thermosensitive liposomes. Magn Reson Med 54:1020–1024PubMedCrossRef
79.
go back to reference Tarner IH, Nakajima A, Seroogy CM, Ermann J, Levicnik A, Contag CH, Fathman CG (2002) Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. Clin Immunol 105:304–314PubMedCrossRef Tarner IH, Nakajima A, Seroogy CM, Ermann J, Levicnik A, Contag CH, Fathman CG (2002) Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. Clin Immunol 105:304–314PubMedCrossRef
80.
go back to reference Tarner IH, Slavin AJ, McBride J, Levicnik A, Smith R, Nolan GP, Contag CH, Fathman CG (2003) Treatment of autoimmune disease by adoptive cellular gene therapy. Ann N Y Acad Sci 998:512–519PubMedCrossRef Tarner IH, Slavin AJ, McBride J, Levicnik A, Smith R, Nolan GP, Contag CH, Fathman CG (2003) Treatment of autoimmune disease by adoptive cellular gene therapy. Ann N Y Acad Sci 998:512–519PubMedCrossRef
81.
go back to reference Leo BM, Li X, Balian G, Anderson DG (2004) In vivo bioluminescent imaging of virus-mediated gene transfer and transduced cell transplantation in the intervertebral disc. Spine 29:838–844PubMedCrossRef Leo BM, Li X, Balian G, Anderson DG (2004) In vivo bioluminescent imaging of virus-mediated gene transfer and transduced cell transplantation in the intervertebral disc. Spine 29:838–844PubMedCrossRef
82.
go back to reference Song Y, Morikawa S, Morita M, Inubushi T, Takada T, Torii R, Tooyama I (2006) Magnetic resonance imaging using hemagglutinating virus of Japan-envelope vector successfully detects localization of intra-cardially administered microglia in normal mouse brain. Neurosci Lett 395:42–45PubMedCrossRef Song Y, Morikawa S, Morita M, Inubushi T, Takada T, Torii R, Tooyama I (2006) Magnetic resonance imaging using hemagglutinating virus of Japan-envelope vector successfully detects localization of intra-cardially administered microglia in normal mouse brain. Neurosci Lett 395:42–45PubMedCrossRef
83.
go back to reference Hauger O, Delalande C, Deminiere C, Fouqueray B, Ohayon C, Garcia S, Trillaud H, Combe C, Grenier N (2000) Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. Radiology 217:819–826PubMed Hauger O, Delalande C, Deminiere C, Fouqueray B, Ohayon C, Garcia S, Trillaud H, Combe C, Grenier N (2000) Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. Radiology 217:819–826PubMed
84.
go back to reference Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499PubMedCrossRef Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499PubMedCrossRef
85.
go back to reference Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J, Gambhir SS, Witte ON (2003) Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A 100:1232–1237PubMedCrossRef Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J, Gambhir SS, Witte ON (2003) Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A 100:1232–1237PubMedCrossRef
86.
go back to reference Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O’Reilly RJ, Larson SM, Tjuvajev JG (2003) Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 21:405–413PubMedCrossRef Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O’Reilly RJ, Larson SM, Tjuvajev JG (2003) Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 21:405–413PubMedCrossRef
87.
go back to reference de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23:1407–1413PubMedCrossRef de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23:1407–1413PubMedCrossRef
88.
go back to reference Daley GQ, Goodell MA, Snyder EY (2003) Realistic prospects for stem cell therapeutics. Hematology (Am Soc Hematol Educ Program):398–418 Daley GQ, Goodell MA, Snyder EY (2003) Realistic prospects for stem cell therapeutics. Hematology (Am Soc Hematol Educ Program):398–418
89.
go back to reference Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH Jr, Bulte JW (2003) Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480–487PubMedCrossRef Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH Jr, Bulte JW (2003) Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480–487PubMedCrossRef
90.
go back to reference Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99:16267–16272PubMedCrossRef Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99:16267–16272PubMedCrossRef
91.
go back to reference Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS, Weissman IL, Contag CH (2004) Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 101:221–226PubMedCrossRef Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS, Weissman IL, Contag CH (2004) Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 101:221–226PubMedCrossRef
92.
go back to reference Guilhon E, Voisin P, de Zwart JA, Quesson B, Salomir R, Maurange C, Bouchaud V, Smirnov P, de Verneuil H, Vekris A, Canioni P, Moonen CT (2003) Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound. J Gene Med 5:333–342PubMedCrossRef Guilhon E, Voisin P, de Zwart JA, Quesson B, Salomir R, Maurange C, Bouchaud V, Smirnov P, de Verneuil H, Vekris A, Canioni P, Moonen CT (2003) Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound. J Gene Med 5:333–342PubMedCrossRef
93.
go back to reference Letavernier B, Salomir R, Delmas Y, Rome C, Couillaud F, Desmouliere A, Hauger O, Grenier N, Combe C, Ripoche J, Moonen C (2006) Spatio-temporal expression control of a heat shock promoter-driven transgene delivered in the kidney by modified mesenchymal stem cells: a feasibility study using MR guided focused ultrasound. International Society for Magnetic Resonance in Medicine 14th Scientific Meeting and Exhibition, 6–12th May 2006, Seattle, Washington, USA Letavernier B, Salomir R, Delmas Y, Rome C, Couillaud F, Desmouliere A, Hauger O, Grenier N, Combe C, Ripoche J, Moonen C (2006) Spatio-temporal expression control of a heat shock promoter-driven transgene delivered in the kidney by modified mesenchymal stem cells: a feasibility study using MR guided focused ultrasound. International Society for Magnetic Resonance in Medicine 14th Scientific Meeting and Exhibition, 6–12th May 2006, Seattle, Washington, USA
Metadata
Title
Gene expression and gene therapy imaging
Authors
Claire Rome
Franck Couillaud
Chrit T. W. Moonen
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
European Radiology / Issue 2/2007
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-006-0378-z

Other articles of this Issue 2/2007

European Radiology 2/2007 Go to the issue